Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Sientra: medical device reports filed with FDA

9,068 reports name it as the manufacturer of the device involved, 2008–2025.

9,068
reports naming it as manufacturer
0% of all MAUDE reports
0
reports, 12 months to August 2026
1,065 in the 12 months before
0.5%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

9,068 medical device reports received by FDA give Sientra as the manufacturer of the device involved, 0% of the MAUDE database, from July 2008 to June 2025. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

0 reports arrived in the 12 months to August 2026, against 1,065 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.5%) and malfunction (0.5%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
Sientra Opus Silicone Gel Breast ImplantProsthesis, breast, noninflatable, internal, silicone gel-filled4,58200%
Sientra Silicone Gel Breast ImplantsProsthesis, breast, noninflatable, internal, silicone gel-filled3,5261,6820%
Sientra Silicone Gel Breast ImplantProsthesis, breast, noninflatable, internal, silicone gel-filled62800%
miraDry SystemInstrument for treatment of hyperhidrosis31460.3%
Breast ImplantsProsthesis, breast, noninflatable, internal, silicone gel-filled14201.1%
Silicone Breast ImplantsProsthesis, breast, noninflatable, internal, silicone gel-filled720%
Breast ImplantProsthesis, breast, noninflatable, internal, silicone gel-filled5971.3%
Silicone Breast ImplantProsthesis, breast, noninflatable, internal, silicone gel-filled250.4%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
FTRProsthesis, breast, noninflatable, internal, silicone gel-filled9,02799.5%
LCJTissue expander and accessories871%
OUBInstrument for treatment of hyperhidrosis320.4%
FWMProsthesis, breast, inflatable, internal, saline20%

Reports by month, five years

0123246Sep 2021: 150Oct 2021: 99Nov 2021: 181Dec 2021: 1682022Jan 2022: 154Feb 2022: 131Mar 2022: 133Apr 2022: 189May 2022: 155Jun 2022: 135Jul 2022: 130Aug 2022: 171Sep 2022: 177Oct 2022: 227Nov 2022: 167Dec 2022: 1592023Jan 2023: 187Feb 2023: 163Mar 2023: 176Apr 2023: 218May 2023: 161Jun 2023: 101Jul 2023: 246Aug 2023: 199Sep 2023: 140Oct 2023: 213Nov 2023: 204Dec 2023: 1362024Jan 2024: 203Feb 2024: 199Mar 2024: 144Apr 2024: 234May 2024: 162Jun 2024: 104Jul 2024: 204Aug 2024: 138Sep 2024: 110Oct 2024: 215Nov 2024: 133Dec 2024: 1342025Jan 2025: 204Feb 2025: 144Mar 2025: 121Apr 2025: 2May 2025: 1Jun 2025: 1Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death0%0
Injury99.5%9,019
Malfunction0.5%47
Other0%0
Not given0%2

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Sientra reports

How many FDA device reports name Sientra as manufacturer?

9,068 reports through August 2026, 0 of them in the latest 12 months.

Which of its brands appear most often?

Sientra Opus Silicone Gel Breast Implant (4,582), Sientra Silicone Gel Breast Implants (3,526), Sientra Silicone Gel Breast Implant (628), miraDry System (31) and Breast Implants (14).

Which device types does it report on?

prosthesis, breast, noninflatable, internal, silicone gel-filled (99.5%), tissue expander and accessories (1%), instrument for treatment of hyperhidrosis (0.4%) and prosthesis, breast, inflatable, internal, saline (0%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.